UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:August 11,
Viking Therapeutics (NASDAQ:VKTX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Viking Therapeutics Charts.
Viking Therapeutics (NASDAQ:VKTX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Viking Therapeutics Charts.

Viking Therapeutics, Inc. News

Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Thursday 25 April 2024 (3 weeks ago) • PR Newswire (US)
U.S. Futures Display Mixed Results Amid Earnings, WTI and Brent Crude Prices Dip in June Futures Trading
Wednesday 24 April 2024 (3 weeks ago) • IH Market News
Viking Therapeutics to Report Financial Results for First Quarter 2024 on April 24, 2024
Thursday 18 April 2024 (4 weeks ago) • PR Newswire (US)
Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of Dual GLP-1/GIP Receptor Agonist VK2735
Tuesday 26 March 2024 (2 months ago) • PR Newswire (US)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)
Viking Therapeutics Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Tuesday 5 March 2024 (2 months ago) • PR Newswire (US)
Form 424B5 - Prospectus [Rule 424(b)(5)]
Saturday 2 March 2024 (2 months ago) • Edgar (US Regulatory)
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
Thursday 29 February 2024 (2 months ago) • PR Newswire (US)
Form 424B5 - Prospectus [Rule 424(b)(5)]
Wednesday 28 February 2024 (3 months ago) • Edgar (US Regulatory)
Viking Therapeutics Announces Proposed Public Offering of Common Stock
Wednesday 28 February 2024 (3 months ago) • PR Newswire (US)

More Viking Therapeutics, Inc. News Articles

Your Recent History

FX
USDJPY
US Dollar vs Yen
NYSE
IVAN.WS
Ivanhoe Capital Acquisit...
Delayed Upgrade Clock